| Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets K Schulze, S Imbeaud, E Letouzé, LB Alexandrov, J Calderaro, ... Nature genetics 47 (5), 505-511, 2015 | 1641 | 2015 |
| Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma C Guichard, G Amaddeo, S Imbeaud, Y Ladeiro, L Pelletier, IB Maad, ... Nature genetics 44 (6), 694-698, 2012 | 1538 | 2012 |
| SDH mutations establish a hypermethylator phenotype in paraganglioma E Letouzé, C Martinelli, C Loriot, N Burnichon, N Abermil, C Ottolenghi, ... Cancer cell 23 (6), 739-752, 2013 | 755 | 2013 |
| Integrated genomic characterization of adrenocortical carcinoma G Assié, E Letouzé, M Fassnacht, A Jouinot, W Luscap, O Barreau, ... Nature genetics 46 (6), 607-612, 2014 | 649 | 2014 |
| Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification J Calderaro, G Couchy, S Imbeaud, G Amaddeo, E Letouzé, JF Blanc, ... Journal of hepatology 67 (4), 727-738, 2017 | 593 | 2017 |
| Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas JC Nault, S Datta, S Imbeaud, A Franconi, M Mallet, G Couchy, E Letouzé, ... Nature genetics 47 (10), 1187-1193, 2015 | 499 | 2015 |
| DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma A Villanueva, A Portela, S Sayols, C Battiston, Y Hoshida, ... Hepatology 61 (6), 1945-1956, 2015 | 385 | 2015 |
| EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype S Rebouissou, I Bernard-Pierrot, A de Reyniès, ML Lepage, C Krucker, ... Science translational medicine 6 (244), 244ra91-244ra91, 2014 | 365 | 2014 |
| Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation JC Nault, G Couchy, C Balabaud, G Morcrette, S Caruso, JF Blanc, ... Gastroenterology 152 (4), 880-894. e6, 2017 | 362 | 2017 |
| Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation C Pilati, E Letouzé, JC Nault, S Imbeaud, A Boulai, J Calderaro, ... Cancer cell 25 (4), 428-441, 2014 | 269 | 2014 |
| Genotype‐phenotype correlation of CTNNB1 mutations reveals different ß‐catenin activity associated with liver tumor progression S Rebouissou, A Franconi, J Calderaro, E Letouzé, S Imbeaud, C Pilati, ... Hepatology 64 (6), 2047-2061, 2016 | 256 | 2016 |
| Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis E Letouzé, J Shinde, V Renault, G Couchy, JF Blanc, E Tubacher, ... Nature communications 8 (1), 1315, 2017 | 249 | 2017 |
| Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas LJ Castro-Vega, E Letouzé, N Burnichon, A Buffet, PH Disderot, E Khalifa, ... Nature communications 6 (1), 6044, 2015 | 193 | 2015 |
| SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma J Hadoux, J Favier, JY Scoazec, S Leboulleux, A Al Ghuzlan, ... International Journal of Cancer 135 (11), 2711-2720, 2014 | 186 | 2014 |
| Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma N Burnichon, A Buffet, B Parfait, E Letouzé, I Laurendeau, C Loriot, ... Human molecular genetics 21 (26), 5397-5405, 2012 | 166 | 2012 |
| Oncometabolites‐driven tumorigenesis: from genetics to targeted therapy A Morin, E Letouzé, AP Gimenez‐Roqueplo, J Favier International journal of cancer 135 (10), 2237-2248, 2014 | 160 | 2014 |
| Clinical impact of genomic diversity from early to advanced hepatocellular carcinoma JC Nault, Y Martin, S Caruso, TZ Hirsch, Q Bayard, J Calderaro, C Charpy, ... Hepatology 71 (1), 164-182, 2020 | 155 | 2020 |
| Analysis of liver cancer cell lines identifies agents with likely efficacy against hepatocellular carcinoma and markers of response S Caruso, AL Calatayud, J Pilet, T La Bella, S Rekik, S Imbeaud, ... Gastroenterology 157 (3), 760-776, 2019 | 154 | 2019 |
| Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas C Pilati, J Shinde, LB Alexandrov, G Assié, T André, Z Hélias‐Rodzewicz, ... The Journal of pathology 242 (1), 10-15, 2017 | 149 | 2017 |
| Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress Q Bayard, L Meunier, C Peneau, V Renault, J Shinde, JC Nault, I Mami, ... Nature Communications 9 (1), 5235, 2018 | 146 | 2018 |
Jessica Zucman-RossiUniversité Paris Cité, AP-HPAdresse e-mail validée de inserm.fr
